Log In
Print this Print this

LPCN 1111

  Manage Alerts
Collapse Summary General Information
Company Lipocine Inc.
DescriptionOnce-daily oral formulation of testosterone using Lipocine's Lip'ral oral delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today